
Abbott wins Health Canada approval for Esprit drug-eluting, dissolving scaffold
Abbott (NYSE: ABT)+
said Health Canada authorized its Esprit BTK Everolimus Eluting Resorbable Scaffold System, a dissolving stent for patients with chronic limb-threatening ischemia (CLTI) below the knee.








